InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 06/22/2018

Re: None

Wednesday, 03/08/2023 12:15:12 PM

Wednesday, March 08, 2023 12:15:12 PM

Post# of 36585
Here's a copy and paste from the May 16th 2022 PR:

"The Company has submitted a request to the FDA to determine and agree on the Study’s potential new primary efficacy endpoints, including the RATE of SUSTAINED clinical resolution of symptoms of COVID-19 which addresses the shift in COVID-19 clinical outcome observed over the course of the pandemic, and, therefore, to have more meaningful study endpoints for the FDA to consider for potential Emergency Use Authorization. The Company expects to obtain FDA agreement on the potential new primary efficacy endpoints in June 2023"

This is from a reddit comment. I haven't verified the claim from the old PR, but if so they've already submitted the rate of sustained resolution of symptoms to the FDA????? They already had this data yet claim they want it again?
Bearish
Bearish